Nehal chopra biography examples
•
Yahoo Finance
Unlock stock picks and a broker-level newsfeed that powers Wall Street.Upgrade Now
Where Do Hedge Funds Stand On bluebird bio Inc (BLUE)?
Debasis Saha
6 min read
In This Article:
Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings. The 13F filings show the hedge funds' and successful investors' positions as of the end of the third quarter. You can find articles about an individual hedge fund's trades on numerous financial news websites. However, in this article we will take a look at their collective moves over the last 5 years and analyze what the smart money thinks of bluebird bio Inc (NASDAQ:BLUE) based on that data.
Is bluebird bio Inc (NASDAQ:BLUE) the right pick for your portfolio? The best stock pickers were becoming less hopeful. The number of long hedge fund bets fell by 2 recently. bluebird bio Inc (NASDAQ:BLUE) was in 35 hedge
•
List of Tiger Cubs (finance)
•
Even before scientists began to clone animals through genetic engineering and "designer" genes, ethical debates have raged on in the medical and scientific communities as to how far people should go to control their own bodies. But a panel of fyra figures with different perspectives on the bioethics debate defended the process to over 100 students and faculty in a discussion held yesterday in Logan Hall. The experts -- including Gina Kolata, a science writer for The New York Times and author of Clone: The Road to Dolly and The Path Ahead; Biochemistry Department Chairperson Ponzy Lu; Penn Center for Bioethics bioethicist Paul Wolpe and Biology Professor Scott Poethig -- described the most recent developments in the field of genetic engineering. "For the first time, through bio-engineering, one can create a human who is not the product of a sperm and egg," Wolpe said. Insisting he was in favor of cloning, Wolpe still stressed that doctors must consider the moral implications of the p